Las Vegas, NV -- (SBWIRE) -- 09/03/2013 -- Arch Therapeutics Inc (OTCBB:ARTH) traded on Monday at $0.39 after 2.34% rise in share price. With market capitalization of 23.30 million, the company share traded at highest of $1.36 and lowest of $0.01.
Arch Therapeutics publicized the financial reports for period ended June 30, 2013. There were no revenues while company paid $0.71 million in selling general and administrative expenses. The company also spent $0.06 million on research and development.
The company suffered net loss of $0.88 million. The loss was $5000 in the first quarter of year ended March 31, 2013.
Arch Therapeutics, Inc., formerly Almah, Inc., is a life science business. It produces polymers including peptides for gel-like barriers formation to cover wounds that controls bleeding. Arch offers rapid termination of bleeding and fluid leakage control in surgery and trauma care. The company’s product AC5 for haemostasis helps in open surgical procedures.
To find out what ChartPoppers projects for Arch Therapeutics Inc for both short term and long term please click here: ARTH
ChartPoppers Spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit ChartPoppers right now and see what it’s all about for yourself! At 30,000 Visitors a Month and growing rapidly ChartPoppers is the hottest thing in Hot Stocks!
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: chartpoppers.com employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://chartpoppers.com/disclaimer. Release of Liability: Through use of this website viewing or using you agree to hold chartpoppers.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. chartpoppers.com affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. chartpoppers.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and chartpoppers.com. We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical. chartpoppers.com, nor any of its affiliates are not registered investment advisors or broker dealers.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)